n,n-dimethyltryptamine has been researched along with dipropyltryptamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, WH; Qu, SJ; Tan, CH; Wang, GF; Yao, SY; Zhu, DY; Zuo, JP | 1 |
| Anderson, LL; Cozzi, NV; Daley, PF; Feih, JT; Gopalakrishnan, A; Ruoho, AE; Shulgin, AT | 1 |
2 other study(ies) available for n,n-dimethyltryptamine and dipropyltryptamine
| Article | Year |
|---|---|
Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
Topics: Antiviral Agents; Cell Survival; DNA, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Structure-Activity Relationship; Tryptamines | 2011 |
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
Topics: Animals; Blood Platelets; Cell Line; Hallucinogens; Humans; N,N-Dimethyltryptamine; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spodoptera; Tetrabenazine; Tritium; Tryptamines; Vesicular Monoamine Transport Proteins | 2009 |